Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Reactions Weekly
Published in: Reactions Weekly 1/2012

01-03-2012 | Case report

Azathioprine/infliximab

Miliary tuberculosis: case report

Published in: Reactions Weekly | Issue 1/2012

Login to get access

Excerpt

An event is serious (FDA MedWatch definition) when the patient outcome is:
  • death
  • life-threatening
  • hospitalisation
  • disability
  • congenital anomaly
  • requires intervention to prevent permanent impairment or damage
…
Literature
1.
Ferrer I, Maroto N, Monton C, Villagrasa R, Lopez A, Clofent J, Hinojosa J.Miliary tuberculosis in a patient with Crohn’s disease. Gastroenterologia y Hepatologia 34: 511-3, No. 7, Aug 2011 - Spain
Metadata
Title
Azathioprine/infliximab
Miliary tuberculosis: case report
Publication date
01-03-2012
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2012
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.2165/00128415-201213920-00027

Other articles of this Issue 1/2012

Reactions Weekly 1/2012 Go to the issue

Case report

Albumin/tolvaptan

Case report

Ethinylestradiol/drospirenone

Case report

Influenza A virus vaccine-H1N1

Case report

Tegafur/uracil

Case report

Loteprednol etabonate

Case report

Idursulfase